• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎患者碱性磷酸酶与前白蛋白比值与肝细胞癌发生的相关性趋势

Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development.

作者信息

Zhen Wen-Chong, Sun Jing, Bai Xue-Ting, Zhang Qian, Li Zi-Han, Zhang Yi-Xin, Xu Rong-Xuan, Wu Wei, Yao Zhi-Han, Pu Chun-Wen, Li Xiao-Feng

机构信息

School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China.

Graduate School, Dalian Medical University, Dalian 116044, Liaoning Province, China.

出版信息

World J Gastroenterol. 2025 Jan 14;31(2):99349. doi: 10.3748/wjg.v31.i2.99349.

DOI:10.3748/wjg.v31.i2.99349
PMID:39811503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11684201/
Abstract

BACKGROUND

Chronic hepatitis B often progresses silently toward hepatocellular carcinoma (HCC), a leading cause of mortality worldwide. Early detection of HCC is crucial, yet challenging.

AIM

To investigate the role of dynamic changes in alkaline phosphatase to prealbumin ratio (APR) in hepatitis B progression to HCC.

METHODS

Data from 4843 patients with hepatitis B (January 2015 to January 2024) were analyzed. HCC incidence rates in males and females were compared using the log-rank test. Data were evaluated using Kaplan-Meier analysis. The Linear Mixed-Effects Model was applied to track the fluctuation of APR levels over time. Furthermore, Joint Modeling of Longitudinal and Survival data was employed to investigate the temporal relationship between APR and HCC risk.

RESULTS

The incidence of HCC was higher in males. To ensure the model's normality assumption, this study applied a logarithmic transformation to APR, yielding ratio. Ratio levels were higher in females ( = 5.26, < 0.01). A 1-unit increase in ratio correlated with a 2.005-fold higher risk of HCC in males (95%CI: 1.653-2.431) and a 2.273-fold higher risk in females (95%CI: 1.620-3.190).

CONCLUSION

Males are more prone to HCC, while females have higher APR levels. Despite no baseline APR link, rising APR indicates a higher HCC risk.

摘要

背景

慢性乙型肝炎常悄然进展为肝细胞癌(HCC),这是全球主要的死亡原因。HCC的早期检测至关重要,但具有挑战性。

目的

探讨碱性磷酸酶与前白蛋白比值(APR)的动态变化在乙型肝炎进展为HCC中的作用。

方法

分析了4843例乙型肝炎患者(2015年1月至2024年1月)的数据。采用对数秩检验比较男性和女性的HCC发病率。使用Kaplan-Meier分析评估数据。应用线性混合效应模型追踪APR水平随时间的波动。此外,采用纵向和生存数据联合建模来研究APR与HCC风险之间随时间变化的关系。

结果

男性的HCC发病率较高。为确保模型的正态性假设,本研究对APR进行对数转换,得到比值。女性的比值水平较高(=5.26,<0.01)。比值每增加1个单位,男性患HCC的风险高2.005倍(95%CI:1.653 - 2.431),女性高2.273倍(95%CI:1.620 - 3.190)。

结论

男性更容易患HCC,而女性的APR水平较高。尽管基线APR无关联,但APR升高表明HCC风险较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/6c3dd0272aae/99349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/bff2a081fa22/99349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/7a7840e17590/99349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/e3d8f2b98cf3/99349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/fc061b2f8cde/99349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/6c3dd0272aae/99349-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/bff2a081fa22/99349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/7a7840e17590/99349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/e3d8f2b98cf3/99349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/fc061b2f8cde/99349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5b/11684201/6c3dd0272aae/99349-g005.jpg

相似文献

1
Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development.乙型肝炎患者碱性磷酸酶与前白蛋白比值与肝细胞癌发生的相关性趋势
World J Gastroenterol. 2025 Jan 14;31(2):99349. doi: 10.3748/wjg.v31.i2.99349.
2
Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.血清五聚素 3 作为慢性乙型肝炎病毒感染肝细胞癌的生物标志物。
Sci Rep. 2020 Nov 20;10(1):20276. doi: 10.1038/s41598-020-77332-3.
3
Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.血清 Mac-2 结合蛋白糖基化异构体与恩替卡韦治疗的慢性乙型肝炎患者肝细胞癌的风险。
J Gastroenterol Hepatol. 2019 Oct;34(10):1817-1823. doi: 10.1111/jgh.14637. Epub 2019 Mar 10.
4
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis.基于非侵入性标志物的模型预测丙型肝炎病毒先进纤维化病毒应答后极低的肝细胞癌风险。
Hepatology. 2020 Dec;72(6):1924-1934. doi: 10.1002/hep.31588. Epub 2020 Nov 10.
5
Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.低水平 HBsAg 和高水平抗-HBs 的共存可能会增加高 HBV 载量的慢性乙型肝炎患者发生肝细胞癌的风险。
Braz J Infect Dis. 2019 Sep-Oct;23(5):343-351. doi: 10.1016/j.bjid.2019.08.007. Epub 2019 Sep 20.
6
Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study.γ-谷氨酰转肽酶与血小板比值及纤维化-4指数预测中国老年慢性乙型肝炎患者发生乙型肝炎病毒相关肝细胞癌:一项单中心回顾性研究
Medicine (Baltimore). 2019 Dec;98(50):e18319. doi: 10.1097/MD.0000000000018319.
7
Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.耐药性慢性乙型肝炎患者发生肝细胞癌的危险因素。
World J Gastroenterol. 2013 Oct 28;19(40):6834-41. doi: 10.3748/wjg.v19.i40.6834.
8
Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.慢性乙型肝炎合并新发肝硬化患者肝细胞癌的风险及预测因素
J Gastroenterol Hepatol. 2016 Dec;31(12):1971-1977. doi: 10.1111/jgh.13422.
9
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection.血清白蛋白水平降低:慢性乙型肝炎病毒感染患者肝细胞癌的前瞻性风险预测指标。
J Viral Hepat. 2024 Dec;31(12):857-865. doi: 10.1111/jvh.14008. Epub 2024 Sep 16.
10
Development of machine learning-based personalized predictive models for risk evaluation of hepatocellular carcinoma in hepatitis B virus-related cirrhosis patients with low levels of serum alpha-fetoprotein.基于机器学习的乙型肝炎病毒相关肝硬化患者低血清甲胎蛋白水平肝癌风险评估个体化预测模型的建立。
Ann Hepatol. 2024 Nov-Dec;29(6):101540. doi: 10.1016/j.aohep.2024.101540. Epub 2024 Aug 15.

引用本文的文献

1
Exploration of the Mechanism of Action of in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation.基于网络药理学、分子对接和体外验证探索[药物名称]治疗肝癌的作用机制
J Hepatocell Carcinoma. 2025 Aug 28;12:1973-1990. doi: 10.2147/JHC.S527095. eCollection 2025.
2
Efficacy and Safety of the Multi-Level Comprehensive Collateral Artery Embolism Sequential Hepatic Arterial Infusion Chemotherapy, Combined with TKI and ICI, for Unresectable Huge Hepatocellular Carcinoma (>10cm): A Propensity Score Matching Cohort Study.多层综合侧支动脉栓塞序贯肝动脉灌注化疗联合TKI和ICI治疗不可切除巨大肝细胞癌(>10cm)的疗效和安全性:一项倾向评分匹配队列研究
J Hepatocell Carcinoma. 2025 Aug 19;12:1821-1834. doi: 10.2147/JHC.S546588. eCollection 2025.

本文引用的文献

1
Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.慢性乙型肝炎不确定期患者显著肝脏炎症的非侵入性诊断。
Virulence. 2023 Dec;14(1):2268497. doi: 10.1080/21505594.2023.2268497. Epub 2023 Nov 8.
2
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.全球肝细胞癌流行病学趋势:对筛查、预防和治疗的启示。
Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26.
3
Mobile Phone Use and Risks of Overall and 25 Site-Specific Cancers: A Prospective Study from the UK Biobank Study.
手机使用与整体和 25 个特定部位癌症风险:来自英国生物银行研究的前瞻性研究。
Cancer Epidemiol Biomarkers Prev. 2024 Jan 9;33(1):88-95. doi: 10.1158/1055-9965.EPI-23-0766.
4
Prognostic value of preoperative prealbumin levels in patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation.术前前白蛋白水平对不可切除肝细胞癌患者经动脉化疗栓塞术的预后价值
Heliyon. 2023 Jul 20;9(8):e18494. doi: 10.1016/j.heliyon.2023.e18494. eCollection 2023 Aug.
5
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma.肝细胞癌发病机制及危险因素中的性别差异
Biology (Basel). 2023 Jul 11;12(7):984. doi: 10.3390/biology12070984.
6
Disparities in care and outcomes for primary liver cancer in England during 2008-2018: a cohort study of 8.52 million primary care population using the QResearch database.2008 - 2018年英格兰原发性肝癌护理与结局的差异:一项使用QResearch数据库对852万初级保健人群的队列研究。
EClinicalMedicine. 2023 May 11;59:101969. doi: 10.1016/j.eclinm.2023.101969. eCollection 2023 May.
7
Joint modelling of longitudinal processes and time-to-event outcomes in heart failure: systematic review and exemplar examining the relationship between serum digoxin levels and mortality.心力衰竭纵向过程和生存时间结局的联合建模:系统评价和示例研究血清地高辛水平与死亡率的关系。
BMC Med Res Methodol. 2023 Apr 19;23(1):94. doi: 10.1186/s12874-023-01918-4.
8
Pune GSH supplementation study: Analyzing longitudinal changes in type 2 diabetic patients using linear mixed-effects models.浦那谷胱甘肽补充研究:使用线性混合效应模型分析2型糖尿病患者的纵向变化。
Front Pharmacol. 2023 Mar 13;14:1139673. doi: 10.3389/fphar.2023.1139673. eCollection 2023.
9
Global Epidemiology and Genetics of Hepatocellular Carcinoma.全球肝细胞癌的流行病学和遗传学
Gastroenterology. 2023 Apr;164(5):766-782. doi: 10.1053/j.gastro.2023.01.033. Epub 2023 Feb 2.
10
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances.肝炎病毒与肝细胞癌:最新进展
Cancers (Basel). 2023 Jan 15;15(2):533. doi: 10.3390/cancers15020533.